期刊文献+

头孢吡肟治疗老年人院内获得性呼吸道感染31例 被引量:1

Cefepime in treating hospital acquired respiratory tract infections in 31 elderly patients
下载PDF
导出
摘要 目的 :评价头孢吡肟对老年人院内获得性呼吸道感染的临床疗效和安全性。方法 :院内呼吸道感染病人 31例 ,用头孢吡肟 4g/ d,分 2次 iv gtt,其中 1例肾功能减退者 ,2 g,iv,gtt qd,疗程 7~ 14d。结果 :治疗后临床有效率 77.4% ,痊愈率5 1.6 % ,细菌清除率 6 9.2 % ,不良反应少而轻微 ,发生率为 6 .5 %。结论 AIM: To evaluate the efficacy and safety of cefepime in treating hospital acquired respiratory tract infections in elderly. METHODS: Thirty one patients with respiratory tract infections were selected. Cefepime was injected in a dosage of 4 g/d for 7-14 d, twice daily. One patient with impaired renal function, cefepime was administered intravenously in a dosage of 2 g/d, once daily. RESULTS: The total effective rate, cure rate, and bacterial clearance rate were 77 4%, 51 6% and 69 2%, respectively. Adverse drug reactions, that were rare and mild, were observed in 6 5% patients. CONCLUSION: The cefepime has a good efficacy and safety for treatment of hospital acquired respiratory tract infections in elderly.
出处 《中国临床药学杂志》 CAS 2000年第5期277-278,共2页 Chinese Journal of Clinical Pharmacy
关键词 头孢吡肟 老年人 获得性呼吸道感染 医药内感染 cefepime elderly hospital acquired respiratory tract infections drug evaluation
  • 相关文献

参考文献3

  • 1BryskierA.Newconceptsinthefieldofcephalosporins:C-3′quaternaryammoniumcephems(groupⅣ).ClinMicrobiolInfect,1997,3(Suppl1):s1
  • 2BarradellLB,BrysonHM.Cefepime:Areviewofitsantibacterialactivity,pharmacokineticpropertiesandtherapeuticuse.Drugs,1994,47(3):471
  • 3BarbhaiyaRH,KnuppCA,PittmanKA.Effectsofageandgenderonpharmacokineticsofcefepime.AntimicrobAgentsChemother,1992,36:1181

同被引文献18

  • 1Marshall WF;Blair JE.The cephalosporins: Symposium on Antimicrobial Agents[J],1999.
  • 2Pfaller MA;Jones RN;Doern GV.Multicenter evaluation of the antimicrobial activity for six broad -spectrum betalactams in Venezuela using the E-test method[J],1998.
  • 3West J;Frei R.Multicenter study of the in vitro activity of cefepime in comparison with five other broad-spectrum antibiotics against clinical isolates of Gram-positive and Gram - negative bacteria from hospitalized patients in Switzerland[J],1999.
  • 4Pfaller MA;Korten V;Jones RN;er al.Multicenter evaluation of the antimicrobial activity for seven broad - spectrum beta - lactams in Turkey using the E -test method[J],1999.
  • 5Yamaguchi K;Mathai D;Biedenbach DJ;er al.Evaluation of the in vitro activity of six broad - spectrum beta - lactam antimicrobial agents tested against over 2000 clinical isolates from 22 medical centers in Japan[J],1999(2).
  • 6Sanders CC.In vitro activity of fourth generation cephalosporins against enterbacteriaceae producing extended - spectrum beta - lactamases,1996(02).
  • 7Struelens MJ;ByL B;Vincent J.Antibiotic policy: a toll for controlling resistance of hospital pathogens[J],1999.
  • 8Schaad UB;Eskola J;Kafetzis D.Cefepime VS. ceftazidime treatment of pyelonephritis: a European, randomized, controlled study of 300 pediatric cases,1998.
  • 9Mustafa MM.Cefepime versus ceftazidime in the empiric treatment of febrile neutropenic children with malignancy (Abstract),1997.
  • 10Ruuskanen O;Mertsola J.Childhood community-acquired pneumonia[J],1999.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部